Dr. Sharpe is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3025 112th Ave NE
Ste 200
Bellevue, WA 98004Phone+1 425-451-2020Fax+1 425-450-9696
Education & Training
St Francis Medical CenterResidency, Ophthalmology, 1993 - 1996
UPMC Medical Education/MercyInternship, Internal Medicine, 1992 - 1993
Ohio State University College of MedicineClass of 1992
Certifications & Licensure
IL State Medical License 2016 - 2026
WA State Medical License 2006 - 2026
TX State Medical License 2014 - 2024
MN State Medical License 2008 - 2018
OH State Medical License 1996 - 2018
PA State Medical License 1993 - 1996- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Fellow (FAAO) American Academy of Ophthalmology
Publications & Presentations
PubMed
- 35 citationsTrimethoprim-sulfamethoxazole therapy for ocular toxoplasmosis.E. Mitchel Opremcak, David K. Scales, Matthew R. Sharpe
Ophthalmology. 1992-06-01 - 121 citationsNeutrophil activation during acetaminophen hepatotoxicity and repair in mice and humans.C. David Williams, Mary Lynn Bajt, Matthew R. Sharpe, Mitchell R. McGill, Anwar Farhood
Toxicology and Applied Pharmacology. 2014-03-01 - 515 citationsThe mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation.Mitchell R. McGill, Matthew R. Sharpe, C. David Williams, Mohammad Taha, Steven C. Curry
The Journal of Clinical Investigation. 2012-04-02
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
